| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:1531.)
© 2007 American Heart Association, Inc.
Original Contributions |
From the Lenox Hill Hospital (A.B.), New York, NY; University of Heidelberg Medical Center (M.H.), Heidelberg, Germany; Robert Janker Klinik and Alfried Krupp Krankenhaus (H.H.), Bonn, Germany; National Taiwan University Hospital (H.M.L.), Taipei, Taiwan; Taipei Veterans General Hospital and National Yang Ming University (M.T.), Taipei, Taiwan; National Institute of Neurosurgery (I.S.), Budapest, Hungary; Klinikum der Universität Freiburg (A.B.), Freiburg, Germany; Kreiskrankenhaus Siegen (J.R.), Siegen, Germany; Prince of Wales Hospital (S.Y.), Hong Kong; Universitätsklinikum Essen (M.F.), Essen, Germany; Queen Mary Hospital (M.L.), Hong Kong; Singapore General Hospital (W.L.), Singapore; and Penumbra Inc (S.P.S.), San Leandro, Calif.
Correspondence to Siu Po Sit, PhD, Penumbra Inc, 2401 Merced St, San Leandro, CA 94577. E-mail ssit{at}penumbrainc.com
Background and Purpose— The purpose of this study was to assess the safety and performance of the Wingspan stent system and Gateway percutaneous transluminal angioplasty balloon catheter in the treatment of high-grade, intracranial atherosclerotic lesions in patients who had failed medical therapy.
Methods— In this prospective, multicenter, single-arm study, medically refractory patients with a modified Rankin score
3 and recurrent symptoms attributable to angiographically demonstrated intracranial stenosis
50% in a vessel 2.5 to 4.5 mm in diameter were enrolled. Intracranial lesions were predilated with an undersized Gateway balloon catheter to 80% of the native vessel diameter, followed by deployment of the self-expanding Wingspan stent to facilitate further remodeling of the atherosclerotic plaque and to maintain vessel patency. Neurologic examinations and angiograms were performed at 6 months after the procedure.
Results— Among the 45 patients enrolled, the degree of stenosis was reduced from a baseline of 74.9±9.8% to 31.9±13.6% after stenting and 28±23.2% at the 6-month follow-up. The 30-day composite ipsilateral stroke/death rate was 4.5% (2/44); at the 6-month follow-up, the ipsilateral stroke/death rate was 7.0%, the rate for all strokes was 9.7%, and all-cause mortality was 2.3%. Physician-reported follow-up in 43 patients (average of 13 months) conducted outside the study protocol (not adjudicated by the clinical event committee) reported 1 additional ipsilateral stroke.
Conclusions— In medically refractory patients with high-grade intracranial atherosclerotic stenoses, a new treatment paradigm involving predilation with an undersized Gateway percutaneous transluminal angioplasty balloon catheter and placement of a self-expanding Wingspan stent system appears to be safe, may facilitate remodeling, and may contribute to favorable angiographic outcomes.
Key Words: atherosclerosis medical therapy nitinol stent stenosis stroke
This article has been cited by other articles:
![]() |
E.I. Levy, L.N. Hopkins, A.S. Turk, D.J. Fiorella, P.A. Rasmussen, T.J. Masaryk, F.C. Albuquerque, C.G. McDougall, G.L. Pride Jr., B.G. Welch, et al. Response to the Commentary "How Do We Spin Wingspan?" AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): e67 - e68. [Full Text] [PDF] |
||||
![]() |
C.P. Derdeyn and M.I. Chimowitz Re: Turk et al and the "How Do We Spin Wingspan?" Commentary AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): e69 - e69. [Full Text] [PDF] |
||||
![]() |
F. Siddiq, G. Vazquez, M. Z. Memon, M. F. K. Suri, R. A. Taylor, J. C. Wojak, J. C. Chaloupka, and A. I. Qureshi Comparison of Primary Angioplasty With Stent Placement for Treating Symptomatic Intracranial Atherosclerotic Diseases: A Multicenter Study Stroke, September 1, 2008; 39(9): 2505 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gupta Symptomatic Intracranial Atherosclerotic Disease: What Is the Best Treatment Option? Stroke, June 1, 2008; 39(6): 1661 - 1662. [Full Text] [PDF] |
||||
![]() |
O. O. Zaidat, R. Klucznik, M. J. Alexander, J. Chaloupka, H. Lutsep, S. Barnwell, M. Mawad, B. Lane, M. J. Lynn, M. Chimowitz, et al. The NIH registry on use of the Wingspan stent for symptomatic70-99% intracranial arterial stenosis Neurology, April 22, 2008; 70(17): 1518 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Haley Jr Registries: They're not just for weddings anymore Neurology, April 22, 2008; 70(17): 1508 - 1509. [Full Text] [PDF] |
||||
![]() |
D.C. Suh, J.K. Kim, J.W. Choi, B.S. Choi, H.W. Pyun, Y.J. Choi, M.-H. Kim, H.R. Yang, H.I. Ha, S.J. Kim, et al. Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 781 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nahab, G. Cotsonis, M. Lynn, E. Feldmann, S. Chaturvedi, J. C. Hemphill, R. Zweifler, K. Johnston, D. Bonovich, S. Kasner, et al. Prevalence and Prognosis of Coexistent Asymptomatic Intracranial Stenosis Stroke, March 1, 2008; 39(3): 1039 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pelz, E. I. Levy, and L. N. Hopkins Advances in Interventional Neuroradiology 2007 Stroke, February 1, 2008; 39(2): 268 - 272. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |